Aortography and peripheral angiography
J9 · Effective Oct 31, 2016
84 active Medicare policies list D32.0, and 7 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 31, 2016
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
7 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of D32.0 |
|---|---|---|
| Bevacizumab for Non-Ocular Indications | Feb 20, 2024 | Covered |
| Chronic Vertigo | Apr 26, 2023 | Covered |
| Indocyanine Green Angiography | Mar 23, 2023 | Covered |
| Intraoperative Neurophysiological Monitoring | Oct 26, 2023 | Covered |
| Myringotomy and Tympanostomy Tube | Jun 7, 2023 | Covered |
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JE · Effective Oct 8, 2018
JF · Effective Oct 8, 2018
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective May 1, 2017
JK · Effective May 1, 2017
J6 · Effective Jul 13, 2025
JK · Effective Jul 13, 2025
J9 · Effective Dec 12, 2021
JH · Effective Dec 12, 2021
JL · Effective Dec 12, 2021
J9 · Effective Oct 1, 2015
J15 · Effective Oct 24, 2016
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Dec 3, 2023
JM · Effective Dec 3, 2023
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J6 · Effective Apr 1, 2026
J9 · Effective Aug 19, 2025
J6 · Effective Jul 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Mar 5, 2026
National · Effective Oct 1, 2026
JL · Effective Oct 1, 2025
J5 · Effective Feb 1, 2024
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
JL · Effective Oct 1, 2025
National · Effective Oct 1, 2026
JL · Effective Oct 1, 2025
J6 · Effective Apr 1, 2026
National · Effective Oct 30, 2025
J6 · Effective Apr 1, 2026
JL · Effective Sep 10, 2026
J9 · Effective Sep 10, 2026
National · Effective Oct 1, 2025
National · Effective Oct 2, 2025
National · Effective Oct 1, 2026
J6 · Effective Apr 1, 2026
National · Effective Mar 26, 2026
National · Effective Oct 1, 2025
J5 · Effective Oct 1, 2025
J6 · Effective Apr 1, 2026
JL · Effective Oct 1, 2023
J5 · Effective Oct 1, 2025
J6 · Effective Apr 1, 2026
National · Effective Nov 6, 2025
| Policy | Effective | Status of D32.0 |
|---|
| Visual Field Testing | Not recorded | Covered |
|---|
| Policy | Effective | Status of D32.0 |
|---|---|---|
| Cryosurgical, Radiofrequency, Microwave or Laser Ablation to Treat Solid Tumors Outside the Liver | Oct 1, 2026 | Covered |